Dyadic International, Inc.
NASDAQ:DYAI
1.94 (USD) • At close January 7, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Dyadic International, Inc. |
Symbool | DYAI |
Munteenheid | USD |
Prijs | 1.94 |
Beurswaarde | 57,403,436 |
Dividendpercentage | 0% |
52-weken bereik | 0.93 - 2.67 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Mark A. Emalfarb |
Website | https://www.dyadic.com |
An error occurred while fetching data.
Over Dyadic International, Inc.
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)